139 related articles for article (PubMed ID: 35609473)
1. Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study.
Kolar J; Llaurado AF; Ulamec M; Skenderi F; Perez-Montiel D; Alvarado-Cabrero I; Bulimbasic S; Sperga M; Tretiakova M; Osunkoya AO; Rogala J; Comperat E; Gal V; Dunatov A; Pivovarcikova K; Michalova K; Vesela AB; Slisarenko M; Strakova AP; Pitra T; Hora M; Michal M; Alaghehbandan R; Hes O
Ann Diagn Pathol; 2022 Oct; 60():151978. PubMed ID: 35609473
[TBL] [Abstract][Full Text] [Related]
2. The Histologic Diversity of Chromophobe Renal Cell Carcinoma With Emphasis on Challenges Encountered in Daily Practice.
Alaghehbandan R; Williamson SR; McKenney JK; Hes O
Adv Anat Pathol; 2022 Jul; 29(4):194-207. PubMed ID: 35470289
[TBL] [Abstract][Full Text] [Related]
3. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.
Foix MP; Dunatov A; Martinek P; Mundó EC; Suster S; Sperga M; Lopez JI; Ulamec M; Bulimbasic S; Montiel DP; Alaghehbandan R; Peckova K; Pivovarcikova K; Ondrej D; Rotterova P; Skenderi F; Prochazkova K; Dusek M; Hora M; Michal M; Hes O
Virchows Arch; 2016 Dec; 469(6):669-678. PubMed ID: 27631338
[TBL] [Abstract][Full Text] [Related]
4. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
5. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis.
Avulova S; Cheville JC; Lohse CM; Gupta S; Potretzke TA; Tsivian M; Thompson RH; Boorjian SA; Leibovich BC; Potretzke AM
Eur Urol; 2021 Feb; 79(2):225-231. PubMed ID: 33172723
[TBL] [Abstract][Full Text] [Related]
6. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including Its Variant Morphologies.
Alaghehbandan R; Trpkov K; Tretiakova M; Luis AS; Rogala JD; Hes O
Adv Anat Pathol; 2021 Jan; 28(1):8-20. PubMed ID: 33021507
[TBL] [Abstract][Full Text] [Related]
8. Differential immunohistochemical and molecular profiling of conventional and aggressive components of chromophobe renal cell carcinoma: pitfalls for diagnosis.
Chen CV; Croom NA; Simko JP; Stohr BA; Chan E
Hum Pathol; 2022 Jan; 119():85-93. PubMed ID: 34800526
[TBL] [Abstract][Full Text] [Related]
9. Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme.
Ohashi R; Martignoni G; Hartmann A; Caliò A; Segala D; Stöhr C; Wach S; Erlmeier F; Weichert W; Autenrieth M; Schraml P; Rupp NJ; Ohe C; Otsuki Y; Kawasaki T; Kobayashi H; Kobayashi K; Miyazaki T; Shibuya H; Usuda H; Umezu H; Fujishima F; Furusato B; Osakabe M; Sugai T; Kuroda N; Tsuzuki T; Nagashima Y; Ajioka Y; Moch H
Virchows Arch; 2020 Mar; 476(3):409-418. PubMed ID: 31760491
[TBL] [Abstract][Full Text] [Related]
10. Small cell variant of chromophobe renal cell carcinoma: Clinicopathologic and molecular-genetic analysis of 10 cases.
Rogala J; Kojima F; Alaghehbandan R; Ptakova N; Bravc A; Bulimbasic S; Perez Montiel D; Slisarenko M; Ali L; Kuthi L; Pivovarcikova K; Michalova K; Bartovic B; Bartos Vesela A; Dolejsova O; Michal M; Hes O
Bosn J Basic Med Sci; 2022 Jul; 22(4):531-539. PubMed ID: 35276058
[TBL] [Abstract][Full Text] [Related]
11. [Pigmented microcystic chromophobe renal cell carcinoma: a clinicopathologic analysis of five cases].
Zhao M; Wang YB; Zhang Q; Jin L; Yang ZR; Zhang X; Ru GQ; Zhang DH; He XL
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):926-930. PubMed ID: 30522173
[No Abstract] [Full Text] [Related]
12. High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset.
Baraban EG; Elias R; Lin MT; Ged Y; Zhu J; Pallavajjala A; Singla N; Lotan TL; Argani P; Eshleman JR; Epstein JI
Mod Pathol; 2024 May; 37(5):100472. PubMed ID: 38492778
[TBL] [Abstract][Full Text] [Related]
13. TSC/MTOR-mutated eosinophilic renal tumors are a distinct entity that is CK7+/CK20-/vimentin-: a validation study.
Tjota MY; Wanjari P; Segal J; Antic T
Hum Pathol; 2021 Sep; 115():84-95. PubMed ID: 33352195
[TBL] [Abstract][Full Text] [Related]
14. Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
Skala SL; Wang X; Zhang Y; Mannan R; Wang L; Narayanan SP; Vats P; Su F; Chen J; Cao X; Siddiqui J; Argani P; Cieślik MP; Giordano TJ; Chinnaiyan AM; Dhanasekaran SM; Mehra R
Eur Urol; 2020 Jul; 78(1):63-74. PubMed ID: 32299640
[TBL] [Abstract][Full Text] [Related]
15. The Role of Genetic Analysis in Correct Diagnosis of Eosinophilic Variant of Chromophobe Renal Cell Carcinoma.
Molnar A; Yusenko MV; Kovacs G; Banyai D
Anticancer Res; 2020 Dec; 40(12):6863-6867. PubMed ID: 33288578
[TBL] [Abstract][Full Text] [Related]
16. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
[TBL] [Abstract][Full Text] [Related]
17. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB
Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597
[TBL] [Abstract][Full Text] [Related]
18. Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series.
Casuscelli J; Becerra MF; Seier K; Manley BJ; Benfante N; Redzematovic A; Stief CG; Hsieh JJ; Tickoo SK; Reuter VE; Coleman JA; Russo P; Ostrovnaya I; Hakimi AA
Clin Genitourin Cancer; 2019 Oct; 17(5):373-379.e4. PubMed ID: 31326335
[TBL] [Abstract][Full Text] [Related]
19. Molecular underpinnings of dedifferentiation and aggressiveness in chromophobe renal cell carcinoma.
Kapur P; Zhong H; Le D; Mukhopadhyay R; Miyata J; Carrillo D; Rakheja D; Rajaram S; Durinck S; Modrusan Z; Brugarolas J
JCI Insight; 2024 Apr; 9(10):. PubMed ID: 38775158
[TBL] [Abstract][Full Text] [Related]
20. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
